Want to see IN:VENUSREM full AI Analyst Report?
Venus Remedies Limited (VENUSREM) Revenue
Venus Remedies Limited Revenue
Venus Remedies Limited had a revenue of 1.79B in the quarter ending Jun 30, 2026, with -31.05%. This bring the company's revenue in the last twelve months to 8.11B, Increased 6.14%. In the fiscal year ending Mar 31, 2026, Venus Remedies Limited had annual revenue of 7.70B with 18.79% growth.
- Revenue (ttm)
- 8.11B
- Revenue Growth
- 20.22%
- P/S Ratio
- 2.14
- Revenue/Employee
- INR 5,228,261
- Employees
- 1,472
- Market Cap
- INR 16.46B
Revenue Chart
Venus Remedies Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.70B | 1.22B | 18.79% |
| Mar 31, 2025 | 6.48B | 564.40M | 9.54% |
| Mar 31, 2024 | 5.91B | 359.40M | 6.47% |
| Mar 31, 2023 | 5.56B | -431.40M | -7.21% |
| Mar 31, 2022 | 5.99B | 505.26M | 9.22% |
| Mar 31, 2021 | 5.48B | 2.11B | 62.83% |
| Mar 31, 2020 | 3.37B | 192.16M | 6.05% |
| Mar 31, 2019 | 3.17B | -520.41M | -14.09% |
| Mar 31, 2018 | 3.69B | -268.04M | -6.76% |
| Mar 31, 2017 | 3.96B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:VENUSREM | 8.11B |
| IN:INDOCO | 18.59B |
| IN:INDSWFTLAB | 6.65B |
| IN:LINCOLN | 7.19B |
| IN:SYNCOMF | 4.98B |
| IN:WINDLAS | 9.42B |